Vhteam.Com > Feeds > Research on the Development of Precision Medicine and Accompanying Diagnosis Industry

Research on the Development of Precision Medicine and Accompanying Diagnosis Industry

中文版 Comment
Research on the Development of Precision Medicine and Accompanying Diagnosis Industry
[Editor's Note] With the realization and development of cancer immunotherapy, some immune drugs have broken through the requirement of screening target drug patients. As long as they are specific patients of a disease, they need not be confirmed by concomitant diagnosis. For example, Merck's Keytruda, the FDA has approved the combination of the drug and chemotherapy as a first-line treatment for patients with non-squamous non-small cell lung cancer metastases without having to detect the expression of PD-1. It can be seen that whether the diagnosis must be accompanied depends to a large extent on the efficacy and safety of the drug itself. This article is from the Institute of Firestone Creation, the author, and is edited by Europa Europa Health for reference by professionals. Precision medicine is based on individual differences of patients. It uses modern molecular biology, big data technology and artificial intelligence technology to analyze patients'living environment and clinical data, to achieve accurate disease classification and diagnosis, and to formulate individualized disease prevention and treatment programs. Compared with traditional medical treatment,...
The results from the Machine Translation
Read More
Relate
Publish information for free
Hots
DayWeekMonth